Differences in age at onset and familial aggregation between clinical types of idiopathic Parkinson's disease

Movement Disorders : Official Journal of the Movement Disorder Society
Alexei KorchounovNikolay N Yakhno

Abstract

Idiopathic Parkinson's disease (PD) can be subdivided by its patterns of motor symptoms into tremor-dominant (TDT), akinetic-rigid (ART), and mixed type (MT). Our objective was to determine whether age at onset and family history are different in these three types. In total, 366 patients with PD were assigned in a standardized approach to one of the three subtypes. Age at onset and family history were obtained in all patients and all presumably affected family members were examined. Mean ages at disease onset were similar in all three groups, but distribution of age at onset was markedly different: monophasic in TDT with a peak around 60 years, biphasic in ART with two peaks, one in the middle of the sixth decade (earlier onset, ART-EO), another during the first half of the seventh decade (later onset, ART-LO), and increasing with age only in MT patients A positive family history was significantly associated only with TDT (odds ratio = 5.7) and ART-EO (odds ratio = 7.8), but not with MT or ART-LO patients. Segregation analysis suggested an autosomal recessive mode of transmission in ART-EO and an autosomal dominant mode of transmission in TDT.

References

Feb 1, 1976·Acta Neurologica Scandinavica·R J Marttila, U K Rinne
Jul 11, 1992·Lancet·E C HirschY Agid
Jan 1, 1991·Movement Disorders : Official Journal of the Movement Disorder Society·D M MaraganoreC D Marsden
Jan 1, 1990·Gerontology·K OkadaT Tsunematsu
Jan 1, 1990·Movement Disorders : Official Journal of the Movement Disorder Society·L I GolbeP H Davis
Aug 1, 1990·Neurology·W KollerC Tanner
Feb 22, 1986·British Medical Journal·W J MutchS K Roy
Sep 1, 1973·Brain : a Journal of Neurology·W E MartinV E Anderson
Feb 1, 1984·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·A Barbeau, M Roy
Mar 1, 1980·Neurology·G RosatiM C Devoto
May 1, 1995·Annals of Neurology·P Vieregge, I Heberlein
Apr 1, 1993·Neurology·A H RajputA Rajput
Nov 1, 1995·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·V BonifatiG Meco
Jan 1, 1997·Annals of Neurology·F J VingerhoetsB J Snow
May 1, 1997·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·R J UittiD B Calne
Mar 21, 1998·Nature Genetics·T GasserR D Horstmann
Sep 25, 1998·Neurology·A AntoniniD Eidelberg
Oct 17, 1998·Nature·E LeroyM H Polymeropoulos
Oct 21, 1998·Neuroepidemiology·S J McCannS M Pond
Dec 18, 1998·American Journal of Medical Genetics·S ZareparsiH Payami
Jan 15, 1999·Human Molecular Genetics·M FarrerJ Hardy
Jun 17, 1999·Journal of Neural Transmission. Supplementum·K A Jellinger
Aug 26, 1999·Neuroepidemiology·B A RybickiJ M Gorell
Oct 27, 2001·Archives of Neurology·J Jankovic, A S Kapadia
Nov 8, 2001·Journal of Neurology·T Gasser
Apr 27, 2002·American Journal of Medical Genetics·N E MaherR H Myers
Aug 10, 2002·Current Neurology and Neuroscience Reports·Kah Leong LimTed M Dawson
Sep 18, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·T FoltynieR A Barker
Jan 11, 2003·Journal of Neurology·Olaf RiessJörg B Schulz
Mar 7, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Carson R ReiderUNKNOWN and the Parkinson Study Group

❮ Previous
Next ❯

Citations

Sep 17, 2009·European Journal of Applied Physiology·Ilaria CarpinellaMaurizio Ferrarin
May 23, 2006·Journal of Neural Transmission·J SpiegelU Dillmann
Jun 1, 2011·Journal of Neural Transmission·Uwe WalterReiner Benecke
Feb 1, 2012·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·L JinC Zhong
May 29, 2014·European Journal of Nuclear Medicine and Molecular Imaging·Valtteri KaasinenTommi Noponen
Sep 3, 2011·Nutrition Reviews·Jamie M SheardGraham K Kerr
Jan 11, 2008·AJNR. American Journal of Neuroradiology·C TessaM Mascalchi
Apr 25, 2006·Annals of Neurology·Shannon K McDonnellWalter A Rocca
Nov 4, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Uwe WalterReiner Benecke
Jun 26, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Ji Youn KimWon Yong Lee
Apr 30, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Evan L Thacker, Alberto Ascherio
Jun 15, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Gail A KangBeate Ritz
Jul 30, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·G O SkeieO B Tysnes
Apr 13, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Jörg SpiegelUlrich Dillmann
Mar 1, 2012·Physiological Measurement·A Yu MeigalM Kankaanpää
Jun 3, 2011·European Journal of Epidemiology·Karin WirdefeldtJack Mandel
Aug 5, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Connie MarrasTiago A Mestre
Nov 20, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Johannes Jernqvist GaareOle-Bjørn Tysnes
Aug 14, 2015·The International Journal of Neuroscience·Huanhuan FengYongjie Li
May 12, 2021·Journal of the Neurological Sciences·Hiroo TerashiHitoshi Aizawa
May 25, 2010·Journal of Communication Disorders·Jamie ReillyJean Neils-Strunjas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.